ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/25 | 2,060 | 2,081 | 2,022 | 2,069 | -23 | -1.1% | 1,258,200 |
| 2023/01/24 | 2,069 | 2,146 | 2,060 | 2,092 | +60 | +3% | 1,769,500 |
| 2023/01/23 | 2,034 | 2,069 | 2,025 | 2,032 | +7 | +0.3% | 899,200 |
| 2023/01/20 | 1,994 | 2,038 | 1,983 | 2,025 | -5 | -0.2% | 1,215,100 |
| 2023/01/19 | 2,150 | 2,172 | 2,014 | 2,030 | -20 | -1% | 3,804,300 |
| 2023/01/18 | 2,020 | 2,061 | 1,984 | 2,050 | +44 | +2.2% | 1,250,600 |
| 2023/01/17 | 2,049 | 2,062 | 1,972 | 2,006 | -23 | -1.1% | 713,300 |
| 2023/01/16 | 2,036 | 2,070 | 2,007 | 2,029 | -16 | -0.8% | 769,000 |
| 2023/01/13 | 2,040 | 2,070 | 2,032 | 2,045 | -19 | -0.9% | 764,000 |
| 2023/01/12 | 2,057 | 2,093 | 2,038 | 2,064 | +14 | +0.7% | 820,000 |
| 2023/01/11 | 1,984 | 2,061 | 1,973 | 2,050 | +67 | +3.4% | 1,110,100 |
| 2023/01/10 | 1,985 | 2,010 | 1,944 | 1,983 | -39 | -1.9% | 1,658,800 |
| 2023/01/06 | 1,993 | 2,067 | 1,984 | 2,022 | +12 | +0.6% | 1,580,600 |
| 2023/01/05 | 2,035 | 2,036 | 1,957 | 2,010 | +15 | +0.8% | 1,505,300 |
| 2023/01/04 | 2,055 | 2,059 | 1,968 | 1,995 | -82 | -3.9% | 2,078,600 |
| 2022/12/30 | 1,985 | 2,133 | 1,973 | 2,077 | +110 | +5.6% | 3,113,400 |
| 2022/12/29 | 1,915 | 1,967 | 1,880 | 1,967 | +12 | +0.6% | 1,778,200 |
| 2022/12/28 | 1,988 | 2,020 | 1,902 | 1,955 | -10 | -0.5% | 4,053,100 |
| 2022/12/27 | 1,795 | 1,986 | 1,773 | 1,965 | +328 | +20% | 5,561,900 |
| 2022/12/26 | 1,686 | 1,686 | 1,622 | 1,637 | -49 | -2.9% | 718,600 |
| 2022/12/23 | 1,614 | 1,711 | 1,608 | 1,686 | +49 | +3% | 1,160,100 |
| 2022/12/22 | 1,670 | 1,670 | 1,567 | 1,637 | +95 | +6.2% | 1,534,200 |
| 2022/12/21 | 1,580 | 1,594 | 1,525 | 1,542 | -36 | -2.3% | 835,100 |
| 2022/12/20 | 1,589 | 1,610 | 1,554 | 1,578 | -18 | -1.1% | 967,400 |
| 2022/12/19 | 1,643 | 1,643 | 1,596 | 1,596 | -79 | -4.7% | 810,100 |
| 2022/12/16 | 1,683 | 1,702 | 1,652 | 1,675 | -70 | -4% | 1,112,100 |
| 2022/12/15 | 1,718 | 1,770 | 1,714 | 1,745 | +28 | +1.6% | 1,064,900 |
| 2022/12/14 | 1,730 | 1,753 | 1,706 | 1,717 | +38 | +2.3% | 934,200 |
| 2022/12/13 | 1,745 | 1,762 | 1,662 | 1,679 | -13 | -0.8% | 1,021,800 |
| 2022/12/12 | 1,629 | 1,700 | 1,624 | 1,692 | +45 | +2.7% | 1,084,100 |
| 2022/12/09 | 1,600 | 1,654 | 1,598 | 1,647 | +82 | +5.2% | 1,077,500 |
| 2022/12/08 | 1,570 | 1,587 | 1,545 | 1,565 | +9 | +0.6% | 832,000 |
| 2022/12/07 | 1,550 | 1,592 | 1,544 | 1,556 | -22 | -1.4% | 911,100 |
| 2022/12/06 | 1,597 | 1,622 | 1,578 | 1,578 | -51 | -3.1% | 1,003,600 |
| 2022/12/05 | 1,639 | 1,652 | 1,622 | 1,629 | -20 | -1.2% | 544,500 |
| 2022/12/02 | 1,710 | 1,716 | 1,649 | 1,649 | -74 | -4.3% | 701,300 |
| 2022/12/01 | 1,767 | 1,777 | 1,710 | 1,723 | +11 | +0.6% | 670,000 |
| 2022/11/30 | 1,722 | 1,736 | 1,706 | 1,712 | -50 | -2.8% | 770,500 |
| 2022/11/29 | 1,784 | 1,788 | 1,747 | 1,762 | -20 | -1.1% | 632,500 |
| 2022/11/28 | 1,792 | 1,802 | 1,775 | 1,782 | -28 | -1.5% | 551,700 |
| 2022/11/25 | 1,842 | 1,853 | 1,797 | 1,810 | -31 | -1.7% | 645,800 |
| 2022/11/24 | 1,879 | 1,914 | 1,837 | 1,841 | +3 | +0.2% | 918,000 |
| 2022/11/22 | 1,822 | 1,883 | 1,817 | 1,838 | +30 | +1.7% | 814,700 |
| 2022/11/21 | 1,869 | 1,871 | 1,808 | 1,808 | -80 | -4.2% | 1,146,800 |
| 2022/11/18 | 1,935 | 1,947 | 1,875 | 1,888 | -70 | -3.6% | 1,144,700 |
| 2022/11/17 | 1,926 | 1,968 | 1,915 | 1,958 | -6 | -0.3% | 732,800 |
| 2022/11/16 | 1,982 | 1,984 | 1,904 | 1,964 | -25 | -1.3% | 1,351,300 |
| 2022/11/15 | 1,995 | 1,999 | 1,927 | 1,989 | +8 | +0.4% | 1,861,700 |
| 2022/11/14 | 1,851 | 1,986 | 1,848 | 1,981 | +166 | +9.1% | 2,975,700 |
| 2022/11/11 | 1,615 | 1,853 | 1,609 | 1,815 | +312 | +20.8% | 4,594,000 |
601～
650
件表示中 / 2951件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | 152,900円 | +5.0% | +1.5% | 0.00% | 13.08倍 | 3.48倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 日本新薬 | 309,000円 | +8.0% | -15.3% | 4.01% | 8.67倍 | 0.84倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 180,500円 | +5.9% | +684.6% | 3.05% | 11.98倍 | 1.20倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 398,500円 | +3.6% | +6.1% | 3.01% | 13.42倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
市場注目の銘柄
チャート関連のコラム
